Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neoplasms | 33 | 2024 | 22350 | 0.800 |
Why?
|
Genomics | 32 | 2024 | 5922 | 0.770 |
Why?
|
Lung Neoplasms | 21 | 2024 | 13489 | 0.740 |
Why?
|
Mutation | 47 | 2025 | 30214 | 0.690 |
Why?
|
DNA Copy Number Variations | 18 | 2024 | 2045 | 0.630 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 12 | 2024 | 5389 | 0.600 |
Why?
|
Carcinosarcoma | 1 | 2017 | 108 | 0.520 |
Why?
|
Aneuploidy | 6 | 2023 | 573 | 0.520 |
Why?
|
Gene Expression Regulation, Neoplastic | 22 | 2024 | 8623 | 0.510 |
Why?
|
Epigenomics | 3 | 2021 | 958 | 0.470 |
Why?
|
Quantitative Trait Loci | 1 | 2022 | 2133 | 0.450 |
Why?
|
Genome, Human | 11 | 2021 | 4443 | 0.400 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 3 | 2 | 2021 | 20 | 0.360 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 10 | 2023 | 1762 | 0.350 |
Why?
|
Glioma | 6 | 2025 | 3498 | 0.340 |
Why?
|
DNA Methylation | 15 | 2021 | 4427 | 0.330 |
Why?
|
Endometrial Neoplasms | 5 | 2018 | 1381 | 0.320 |
Why?
|
High-Throughput Nucleotide Sequencing | 9 | 2024 | 3667 | 0.310 |
Why?
|
Uterine Neoplasms | 1 | 2017 | 1424 | 0.300 |
Why?
|
Loss of Heterozygosity | 5 | 2023 | 663 | 0.290 |
Why?
|
Breast Neoplasms, Male | 2 | 2020 | 213 | 0.280 |
Why?
|
PPAR gamma | 2 | 2022 | 484 | 0.280 |
Why?
|
Proto-Oncogene Proteins c-met | 4 | 2020 | 562 | 0.280 |
Why?
|
Germ Cells | 2 | 2022 | 644 | 0.260 |
Why?
|
MicroRNAs | 10 | 2021 | 3789 | 0.250 |
Why?
|
Oncogenes | 6 | 2023 | 1232 | 0.240 |
Why?
|
Cloning, Molecular | 1 | 2010 | 4168 | 0.240 |
Why?
|
Proto-Oncogene Proteins | 7 | 2023 | 4523 | 0.240 |
Why?
|
Databases, Genetic | 7 | 2021 | 1756 | 0.230 |
Why?
|
Cell Line, Tumor | 16 | 2022 | 17089 | 0.230 |
Why?
|
Isocitrate Dehydrogenase | 4 | 2025 | 951 | 0.230 |
Why?
|
Humans | 107 | 2025 | 766812 | 0.220 |
Why?
|
Angiopoietin-2 | 1 | 2025 | 186 | 0.220 |
Why?
|
Cholangiocarcinoma | 2 | 2021 | 562 | 0.220 |
Why?
|
Carcinoma, Squamous Cell | 5 | 2021 | 4050 | 0.220 |
Why?
|
Bile Duct Neoplasms | 2 | 2021 | 614 | 0.220 |
Why?
|
Brain Neoplasms | 6 | 2025 | 9101 | 0.220 |
Why?
|
Tumor Suppressor Proteins | 7 | 2020 | 2801 | 0.220 |
Why?
|
Protein Kinase Inhibitors | 6 | 2024 | 5690 | 0.210 |
Why?
|
Tumor Suppressor Protein p53 | 6 | 2019 | 2952 | 0.210 |
Why?
|
RNA, Transfer, Leu | 1 | 2022 | 13 | 0.210 |
Why?
|
NF-E2-Related Factor 2 | 4 | 2024 | 382 | 0.210 |
Why?
|
Colorectal Neoplasms | 4 | 2025 | 6965 | 0.210 |
Why?
|
Software | 3 | 2022 | 4464 | 0.210 |
Why?
|
Epithelial-Mesenchymal Transition | 3 | 2018 | 754 | 0.200 |
Why?
|
Pyridazines | 2 | 2021 | 199 | 0.200 |
Why?
|
Neoplasms, Glandular and Epithelial | 2 | 2018 | 488 | 0.200 |
Why?
|
Interferons | 2 | 2024 | 716 | 0.200 |
Why?
|
Ovarian Neoplasms | 4 | 2025 | 4903 | 0.200 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 2 | 2021 | 212 | 0.200 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 4 | 2020 | 904 | 0.190 |
Why?
|
Prognosis | 16 | 2025 | 29959 | 0.190 |
Why?
|
Molecular Targeted Therapy | 7 | 2024 | 2823 | 0.190 |
Why?
|
Phosphatidylinositol 3-Kinases | 5 | 2018 | 2882 | 0.190 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2020 | 5330 | 0.190 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2023 | 1757 | 0.190 |
Why?
|
Genes, Essential | 2 | 2020 | 185 | 0.190 |
Why?
|
Neoplasms, Squamous Cell | 1 | 2021 | 95 | 0.190 |
Why?
|
Alkylating Agents | 1 | 2021 | 132 | 0.180 |
Why?
|
Tachykinins | 1 | 2021 | 78 | 0.180 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2021 | 2887 | 0.170 |
Why?
|
SOXB1 Transcription Factors | 1 | 2021 | 283 | 0.170 |
Why?
|
DNA Polymerase II | 2 | 2018 | 103 | 0.170 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2020 | 146 | 0.170 |
Why?
|
Germ-Line Mutation | 4 | 2023 | 1886 | 0.160 |
Why?
|
Genetics, Population | 2 | 2021 | 943 | 0.160 |
Why?
|
Vacuolar Proton-Translocating ATPases | 1 | 2020 | 196 | 0.160 |
Why?
|
Breast Neoplasms | 8 | 2024 | 21162 | 0.160 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2023 | 2841 | 0.160 |
Why?
|
Nuclear Proteins | 8 | 2021 | 5795 | 0.160 |
Why?
|
Gene Amplification | 5 | 2024 | 1088 | 0.160 |
Why?
|
Chromosomes, Human, Pair 1 | 2 | 2018 | 640 | 0.150 |
Why?
|
Genes, Tumor Suppressor | 2 | 2023 | 1057 | 0.150 |
Why?
|
Chromatin | 4 | 2024 | 2980 | 0.150 |
Why?
|
Exons | 3 | 2020 | 2392 | 0.150 |
Why?
|
RNA-Binding Proteins | 4 | 2020 | 1885 | 0.150 |
Why?
|
Transcription Factors, TFII | 1 | 2018 | 62 | 0.150 |
Why?
|
eIF-2 Kinase | 1 | 2018 | 146 | 0.150 |
Why?
|
ras Proteins | 3 | 2018 | 1055 | 0.150 |
Why?
|
DNA Topoisomerases, Type II | 1 | 2018 | 121 | 0.150 |
Why?
|
Adipocytes | 4 | 2005 | 1196 | 0.150 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2018 | 53 | 0.150 |
Why?
|
Signal Transduction | 16 | 2018 | 23618 | 0.150 |
Why?
|
bcl-X Protein | 1 | 2019 | 412 | 0.150 |
Why?
|
Genome | 3 | 2021 | 1753 | 0.140 |
Why?
|
Chromosomal Instability | 1 | 2018 | 176 | 0.140 |
Why?
|
Osteosarcoma | 1 | 2023 | 908 | 0.140 |
Why?
|
Genes, myc | 1 | 2018 | 391 | 0.140 |
Why?
|
Metabolic Networks and Pathways | 2 | 2018 | 800 | 0.130 |
Why?
|
Adenosine Deaminase | 1 | 2018 | 253 | 0.130 |
Why?
|
Gene Expression | 3 | 2022 | 7585 | 0.130 |
Why?
|
Thymoma | 1 | 2018 | 186 | 0.130 |
Why?
|
Transforming Growth Factor beta | 3 | 2018 | 1996 | 0.130 |
Why?
|
BRCA1 Protein | 2 | 2023 | 1155 | 0.130 |
Why?
|
RNA, Messenger | 6 | 2022 | 12795 | 0.130 |
Why?
|
Gene Expression Profiling | 8 | 2022 | 9528 | 0.130 |
Why?
|
Phosphoproteins | 3 | 2017 | 2448 | 0.130 |
Why?
|
Pancreatic Neoplasms | 3 | 2023 | 5444 | 0.130 |
Why?
|
Kidney Neoplasms | 3 | 2020 | 4282 | 0.130 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2017 | 234 | 0.130 |
Why?
|
Telomerase | 3 | 2016 | 750 | 0.130 |
Why?
|
Proteins | 6 | 2013 | 6002 | 0.130 |
Why?
|
Information Dissemination | 1 | 2024 | 1142 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2018 | 361 | 0.130 |
Why?
|
Female | 44 | 2025 | 396532 | 0.130 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2017 | 304 | 0.130 |
Why?
|
Lymphoma, T-Cell | 1 | 2018 | 308 | 0.130 |
Why?
|
Single-Cell Analysis | 2 | 2024 | 2535 | 0.120 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2021 | 1621 | 0.120 |
Why?
|
Endometrial Hyperplasia | 1 | 2016 | 102 | 0.120 |
Why?
|
Adrenocortical Carcinoma | 1 | 2016 | 88 | 0.120 |
Why?
|
Tumor Microenvironment | 4 | 2023 | 3942 | 0.120 |
Why?
|
Cadherins | 2 | 2017 | 903 | 0.120 |
Why?
|
Glioblastoma | 3 | 2024 | 3458 | 0.120 |
Why?
|
Thymus Neoplasms | 1 | 2018 | 272 | 0.120 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2017 | 2186 | 0.120 |
Why?
|
Central Nervous System Neoplasms | 1 | 2023 | 926 | 0.120 |
Why?
|
Interleukin-13 | 1 | 2017 | 391 | 0.120 |
Why?
|
Abdominal Neoplasms | 1 | 2016 | 286 | 0.120 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2017 | 505 | 0.120 |
Why?
|
Adrenal Cortex Neoplasms | 1 | 2016 | 161 | 0.120 |
Why?
|
Gene Regulatory Networks | 3 | 2018 | 1752 | 0.120 |
Why?
|
COS Cells | 2 | 2010 | 1135 | 0.120 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 3 | 2020 | 304 | 0.110 |
Why?
|
Pelvic Neoplasms | 1 | 2016 | 249 | 0.110 |
Why?
|
Genomic Instability | 1 | 2018 | 716 | 0.110 |
Why?
|
Uveal Neoplasms | 1 | 2017 | 344 | 0.110 |
Why?
|
Gene Deletion | 6 | 2020 | 2669 | 0.110 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2019 | 1150 | 0.110 |
Why?
|
Models, Genetic | 2 | 2021 | 3446 | 0.110 |
Why?
|
Genetic Predisposition to Disease | 7 | 2020 | 18076 | 0.110 |
Why?
|
Pleural Neoplasms | 1 | 2018 | 584 | 0.110 |
Why?
|
Enhancer Elements, Genetic | 2 | 2021 | 1366 | 0.110 |
Why?
|
Adaptor Proteins, Signal Transducing | 5 | 2005 | 2902 | 0.110 |
Why?
|
Middle Aged | 27 | 2025 | 223267 | 0.100 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2018 | 497 | 0.100 |
Why?
|
Meningioma | 1 | 2022 | 1221 | 0.100 |
Why?
|
Genes, p53 | 1 | 2015 | 711 | 0.100 |
Why?
|
Gene Targeting | 1 | 2016 | 841 | 0.100 |
Why?
|
Genital Neoplasms, Female | 1 | 2018 | 534 | 0.100 |
Why?
|
Receptor, erbB-2 | 5 | 2024 | 2598 | 0.100 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 1608 | 0.100 |
Why?
|
Meningeal Neoplasms | 1 | 2022 | 1255 | 0.100 |
Why?
|
Aged | 23 | 2025 | 171344 | 0.100 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1994 | 492 | 0.100 |
Why?
|
Mesothelioma | 1 | 2018 | 774 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2018 | 996 | 0.100 |
Why?
|
Cluster Analysis | 5 | 2018 | 2721 | 0.100 |
Why?
|
Carcinoma, Renal Cell | 2 | 2020 | 3186 | 0.100 |
Why?
|
Apoptosis | 4 | 2022 | 9514 | 0.100 |
Why?
|
Testicular Neoplasms | 1 | 2018 | 806 | 0.100 |
Why?
|
Retinol-Binding Proteins, Cellular | 1 | 2011 | 12 | 0.100 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2013 | 199 | 0.100 |
Why?
|
Gene Dosage | 1 | 2016 | 1211 | 0.100 |
Why?
|
Aged, 80 and over | 13 | 2024 | 59548 | 0.100 |
Why?
|
3T3 Cells | 5 | 2005 | 1082 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2022 | 9407 | 0.090 |
Why?
|
Ubiquitin Thiolesterase | 3 | 2020 | 456 | 0.090 |
Why?
|
Carcinoma, Lobular | 1 | 2015 | 480 | 0.090 |
Why?
|
Protein Binding | 6 | 2021 | 9326 | 0.090 |
Why?
|
Adenocarcinoma | 3 | 2018 | 6359 | 0.090 |
Why?
|
Adult | 23 | 2025 | 223305 | 0.090 |
Why?
|
Neoplasm Proteins | 2 | 2020 | 3600 | 0.090 |
Why?
|
RNA Splicing | 3 | 2019 | 903 | 0.090 |
Why?
|
Transcription Factors | 9 | 2021 | 12159 | 0.090 |
Why?
|
Tumor Escape | 1 | 2013 | 371 | 0.090 |
Why?
|
Male | 30 | 2025 | 364154 | 0.090 |
Why?
|
Bone Neoplasms | 1 | 2023 | 2561 | 0.090 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2015 | 614 | 0.090 |
Why?
|
Ligands | 3 | 2022 | 3274 | 0.090 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2018 | 957 | 0.090 |
Why?
|
Carcinoma, Papillary | 1 | 2015 | 791 | 0.090 |
Why?
|
Cell Proliferation | 7 | 2021 | 10451 | 0.090 |
Why?
|
Mice | 17 | 2024 | 81898 | 0.090 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2014 | 1168 | 0.090 |
Why?
|
Age of Onset | 1 | 2017 | 3343 | 0.080 |
Why?
|
Membrane Proteins | 5 | 1996 | 7869 | 0.080 |
Why?
|
DNA, Neoplasm | 1 | 2015 | 1741 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 5 | 2020 | 6514 | 0.080 |
Why?
|
DNA Helicases | 3 | 2021 | 854 | 0.080 |
Why?
|
Phosphorylation | 7 | 2018 | 8310 | 0.080 |
Why?
|
Son of Sevenless Proteins | 5 | 1996 | 27 | 0.080 |
Why?
|
Molecular Sequence Data | 5 | 2014 | 17609 | 0.080 |
Why?
|
Young Adult | 12 | 2025 | 59939 | 0.080 |
Why?
|
Tuberous Sclerosis | 1 | 2017 | 1039 | 0.080 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2020 | 3605 | 0.080 |
Why?
|
Proteomics | 3 | 2022 | 3915 | 0.080 |
Why?
|
Antineoplastic Agents | 5 | 2019 | 13644 | 0.080 |
Why?
|
Chromosome Deletion | 3 | 2020 | 1384 | 0.080 |
Why?
|
Recombinant Fusion Proteins | 4 | 2025 | 3738 | 0.080 |
Why?
|
DNA-Binding Proteins | 7 | 2020 | 9613 | 0.080 |
Why?
|
DNA Damage | 4 | 2020 | 2469 | 0.080 |
Why?
|
Peptides, Cyclic | 1 | 2010 | 390 | 0.080 |
Why?
|
Catalytic Domain | 2 | 2021 | 699 | 0.080 |
Why?
|
Promoter Regions, Genetic | 5 | 2018 | 5795 | 0.070 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2010 | 757 | 0.070 |
Why?
|
Recombinant Proteins | 3 | 2021 | 6507 | 0.070 |
Why?
|
Chromosome Aberrations | 3 | 2023 | 1776 | 0.070 |
Why?
|
Retinoblastoma Protein | 1 | 2011 | 670 | 0.070 |
Why?
|
Evolution, Molecular | 1 | 2016 | 1893 | 0.070 |
Why?
|
Chromosomes | 2 | 2023 | 578 | 0.070 |
Why?
|
MAP Kinase Signaling System | 1 | 2014 | 1492 | 0.070 |
Why?
|
Lysosomes | 1 | 2013 | 937 | 0.070 |
Why?
|
Neoplasm Staging | 2 | 2020 | 11218 | 0.070 |
Why?
|
Platelet-Derived Growth Factor | 3 | 2000 | 616 | 0.070 |
Why?
|
Gene Frequency | 3 | 2020 | 3624 | 0.070 |
Why?
|
Nanoparticles | 1 | 2019 | 1966 | 0.070 |
Why?
|
Cell Line | 6 | 2013 | 15564 | 0.070 |
Why?
|
Base Sequence | 4 | 2022 | 12415 | 0.070 |
Why?
|
DNA Mutational Analysis | 4 | 2020 | 4114 | 0.070 |
Why?
|
Amino Acids | 1 | 2013 | 1711 | 0.070 |
Why?
|
BRCA2 Protein | 2 | 2023 | 802 | 0.070 |
Why?
|
Animals | 20 | 2024 | 168939 | 0.070 |
Why?
|
Protein-Tyrosine Kinases | 3 | 2023 | 2426 | 0.070 |
Why?
|
Stomach Neoplasms | 1 | 2017 | 1480 | 0.070 |
Why?
|
Genes, Neoplasm | 2 | 2018 | 369 | 0.070 |
Why?
|
Gene Knockout Techniques | 2 | 2021 | 804 | 0.070 |
Why?
|
Peptides | 1 | 2018 | 4347 | 0.060 |
Why?
|
Amino Acid Sequence | 3 | 2010 | 13411 | 0.060 |
Why?
|
Cell Death | 2 | 2022 | 1676 | 0.060 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 2000 | 1729 | 0.060 |
Why?
|
DNA Repair | 3 | 2020 | 2050 | 0.060 |
Why?
|
Survival Rate | 4 | 2025 | 12826 | 0.060 |
Why?
|
Adolescent | 10 | 2025 | 88902 | 0.060 |
Why?
|
Immunoblotting | 2 | 2000 | 1647 | 0.060 |
Why?
|
Histone-Lysine N-Methyltransferase | 2 | 2020 | 699 | 0.060 |
Why?
|
Drosophila melanogaster | 1 | 1994 | 1725 | 0.060 |
Why?
|
HEK293 Cells | 3 | 2021 | 4277 | 0.060 |
Why?
|
Angiopoietin-1 | 1 | 2025 | 132 | 0.060 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2020 | 2060 | 0.060 |
Why?
|
Head and Neck Neoplasms | 1 | 2019 | 2930 | 0.060 |
Why?
|
Microsatellite Instability | 2 | 2018 | 726 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2025 | 11876 | 0.060 |
Why?
|
Exoribonucleases | 1 | 2024 | 88 | 0.060 |
Why?
|
Telomere | 2 | 2023 | 943 | 0.060 |
Why?
|
Histone Demethylases | 2 | 2020 | 328 | 0.050 |
Why?
|
Oxidative Phosphorylation | 1 | 2005 | 501 | 0.050 |
Why?
|
Protein Kinases | 2 | 2024 | 1610 | 0.050 |
Why?
|
GRB2 Adaptor Protein | 4 | 1996 | 101 | 0.050 |
Why?
|
Mutagenesis | 2 | 2020 | 1228 | 0.050 |
Why?
|
Adenosine Monophosphate | 2 | 2021 | 232 | 0.050 |
Why?
|
Kinetics | 3 | 2021 | 6288 | 0.050 |
Why?
|
Cell Cycle Proteins | 3 | 2021 | 3440 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2018 | 16044 | 0.050 |
Why?
|
Centromere | 1 | 2023 | 214 | 0.050 |
Why?
|
Antibodies, Monoclonal | 2 | 2017 | 9244 | 0.050 |
Why?
|
CpG Islands | 2 | 2018 | 1208 | 0.050 |
Why?
|
Mice, Nude | 2 | 2019 | 3618 | 0.050 |
Why?
|
Histones | 3 | 2019 | 2595 | 0.050 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2023 | 2056 | 0.050 |
Why?
|
PTEN Phosphohydrolase | 2 | 2020 | 1117 | 0.050 |
Why?
|
Interferon-beta | 1 | 2024 | 348 | 0.050 |
Why?
|
Child | 7 | 2025 | 80670 | 0.050 |
Why?
|
Sequence Analysis, DNA | 3 | 2020 | 4780 | 0.050 |
Why?
|
Calorimetry, Differential Scanning | 1 | 2021 | 93 | 0.050 |
Why?
|
Mutation, Missense | 2 | 2023 | 2591 | 0.050 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2023 | 451 | 0.050 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2013 | 2039 | 0.050 |
Why?
|
Tyrosine-tRNA Ligase | 1 | 2001 | 10 | 0.050 |
Why?
|
Neurospora crassa | 1 | 2001 | 27 | 0.050 |
Why?
|
Tyrosine | 3 | 2001 | 1425 | 0.050 |
Why?
|
Heterotrimeric GTP-Binding Proteins | 1 | 2001 | 94 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 2 | 2010 | 8108 | 0.050 |
Why?
|
Tetrahydroisoquinolines | 1 | 2021 | 81 | 0.050 |
Why?
|
Transfection | 3 | 2000 | 5755 | 0.050 |
Why?
|
Phenotype | 4 | 2021 | 16722 | 0.050 |
Why?
|
ADP-Ribosylation Factors | 1 | 2001 | 131 | 0.050 |
Why?
|
Sucrose | 1 | 2021 | 155 | 0.040 |
Why?
|
Insulin Receptor Substrate Proteins | 2 | 2000 | 558 | 0.040 |
Why?
|
Receptor, Insulin | 2 | 1995 | 839 | 0.040 |
Why?
|
Sequence Analysis, RNA | 2 | 2020 | 2039 | 0.040 |
Why?
|
Receptors, Estrogen | 2 | 2018 | 2252 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2013 | 4926 | 0.040 |
Why?
|
Precipitin Tests | 1 | 2000 | 816 | 0.040 |
Why?
|
Fanconi Anemia Complementation Group Proteins | 1 | 2020 | 98 | 0.040 |
Why?
|
src Homology Domains | 1 | 2000 | 361 | 0.040 |
Why?
|
Guanosine Triphosphate | 3 | 1995 | 315 | 0.040 |
Why?
|
DNA Primase | 1 | 2020 | 110 | 0.040 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2001 | 437 | 0.040 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2001 | 2746 | 0.040 |
Why?
|
Follow-Up Studies | 4 | 2025 | 39312 | 0.040 |
Why?
|
Endoribonucleases | 1 | 2021 | 230 | 0.040 |
Why?
|
Succinate Dehydrogenase | 1 | 2020 | 148 | 0.040 |
Why?
|
RNA Helicases | 1 | 2020 | 144 | 0.040 |
Why?
|
Bone Morphogenetic Protein 5 | 1 | 2018 | 5 | 0.040 |
Why?
|
Mice, Inbred BALB C | 2 | 2019 | 6225 | 0.040 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2020 | 370 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2024 | 1867 | 0.040 |
Why?
|
Protein Methyltransferases | 1 | 2018 | 53 | 0.040 |
Why?
|
Melanoma | 1 | 2017 | 5702 | 0.040 |
Why?
|
Imidazolines | 1 | 2018 | 18 | 0.040 |
Why?
|
Mitochondria | 2 | 2017 | 3678 | 0.040 |
Why?
|
Th1-Th2 Balance | 1 | 2018 | 38 | 0.040 |
Why?
|
Cytokines | 1 | 2013 | 7438 | 0.040 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2020 | 534 | 0.040 |
Why?
|
Introns | 1 | 2001 | 966 | 0.040 |
Why?
|
Epigenesis, Genetic | 3 | 2018 | 3828 | 0.040 |
Why?
|
Smad Proteins | 1 | 2018 | 157 | 0.040 |
Why?
|
Asthma | 1 | 2017 | 6266 | 0.040 |
Why?
|
Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2018 | 69 | 0.040 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2019 | 330 | 0.040 |
Why?
|
Frameshift Mutation | 1 | 2020 | 392 | 0.040 |
Why?
|
Gene Library | 1 | 2000 | 1065 | 0.040 |
Why?
|
Multienzyme Complexes | 1 | 2021 | 663 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-raf | 2 | 2014 | 205 | 0.040 |
Why?
|
Eukaryotic Initiation Factor-1 | 1 | 2017 | 31 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2020 | 784 | 0.040 |
Why?
|
Depsipeptides | 1 | 2018 | 95 | 0.040 |
Why?
|
Karyopherins | 1 | 2018 | 134 | 0.040 |
Why?
|
Monosomy | 1 | 2017 | 52 | 0.040 |
Why?
|
Protein Array Analysis | 1 | 2019 | 399 | 0.040 |
Why?
|
Microtubule-Associated Proteins | 1 | 2022 | 1073 | 0.040 |
Why?
|
SOX9 Transcription Factor | 1 | 2018 | 145 | 0.040 |
Why?
|
DNA, Complementary | 1 | 2000 | 1989 | 0.040 |
Why?
|
G1 Phase | 1 | 2018 | 403 | 0.040 |
Why?
|
Prospective Studies | 4 | 2025 | 54872 | 0.040 |
Why?
|
Seminoma | 1 | 2018 | 136 | 0.030 |
Why?
|
Cryoelectron Microscopy | 1 | 2021 | 645 | 0.030 |
Why?
|
Protein Structure, Tertiary | 2 | 2001 | 3759 | 0.030 |
Why?
|
Mammary Glands, Animal | 1 | 2018 | 273 | 0.030 |
Why?
|
Cohort Studies | 4 | 2022 | 41706 | 0.030 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2018 | 322 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2018 | 6853 | 0.030 |
Why?
|
DNA Mismatch Repair | 1 | 2020 | 431 | 0.030 |
Why?
|
Insulin | 4 | 2001 | 6608 | 0.030 |
Why?
|
Molecular Sequence Annotation | 1 | 2019 | 526 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2018 | 3427 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2015 | 3796 | 0.030 |
Why?
|
Ikaros Transcription Factor | 1 | 2018 | 233 | 0.030 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2019 | 546 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2018 | 228 | 0.030 |
Why?
|
Protein Multimerization | 1 | 2021 | 961 | 0.030 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2020 | 614 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2018 | 4892 | 0.030 |
Why?
|
Nanomedicine | 1 | 2019 | 289 | 0.030 |
Why?
|
DNA Cleavage | 1 | 2016 | 56 | 0.030 |
Why?
|
Epidermal Growth Factor | 2 | 1996 | 697 | 0.030 |
Why?
|
Rats | 2 | 2010 | 23717 | 0.030 |
Why?
|
Muscle Proteins | 1 | 2001 | 1160 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2013 | 10263 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2000 | 1716 | 0.030 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2020 | 1442 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2020 | 2470 | 0.030 |
Why?
|
Antigens, CD | 2 | 2017 | 4033 | 0.030 |
Why?
|
Oncogene Protein v-akt | 1 | 2015 | 130 | 0.030 |
Why?
|
Protein Biosynthesis | 1 | 2022 | 2093 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2018 | 326 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2015 | 6066 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-mos | 1 | 2014 | 17 | 0.030 |
Why?
|
Phosphorus Radioisotopes | 1 | 1995 | 100 | 0.030 |
Why?
|
HeLa Cells | 1 | 2021 | 3073 | 0.030 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2015 | 166 | 0.030 |
Why?
|
Republic of Korea | 1 | 2017 | 591 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1627 | 0.030 |
Why?
|
Janus Kinase 2 | 1 | 2018 | 562 | 0.030 |
Why?
|
Survival Analysis | 2 | 2017 | 10101 | 0.030 |
Why?
|
Documentation | 1 | 2021 | 914 | 0.030 |
Why?
|
Frozen Sections | 1 | 2015 | 153 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2020 | 1250 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2017 | 751 | 0.030 |
Why?
|
Chromosome Breakpoints | 1 | 2014 | 93 | 0.030 |
Why?
|
Intraoperative Period | 1 | 2015 | 512 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2018 | 723 | 0.030 |
Why?
|
Hemagglutinins, Viral | 1 | 1994 | 66 | 0.030 |
Why?
|
Tissue Fixation | 1 | 2015 | 245 | 0.030 |
Why?
|
ras Guanine Nucleotide Exchange Factors | 1 | 1994 | 34 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1105 | 0.030 |
Why?
|
HLA Antigens | 1 | 2019 | 1339 | 0.030 |
Why?
|
Cell Lineage | 1 | 2023 | 2573 | 0.030 |
Why?
|
Core Binding Factor beta Subunit | 1 | 2013 | 42 | 0.030 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2015 | 350 | 0.030 |
Why?
|
Receptor, trkB | 1 | 2014 | 123 | 0.030 |
Why?
|
Insect Hormones | 1 | 1994 | 74 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2021 | 2198 | 0.030 |
Why?
|
Wnt Proteins | 1 | 2018 | 722 | 0.030 |
Why?
|
Actins | 1 | 2001 | 2061 | 0.030 |
Why?
|
Receptor, trkA | 1 | 2014 | 159 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2020 | 1319 | 0.030 |
Why?
|
Muscle, Smooth | 1 | 2017 | 930 | 0.030 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2014 | 258 | 0.030 |
Why?
|
E1A-Associated p300 Protein | 1 | 2013 | 125 | 0.030 |
Why?
|
Cisplatin | 1 | 2019 | 1656 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2025 | 81657 | 0.030 |
Why?
|
Organ Specificity | 1 | 2018 | 1968 | 0.030 |
Why?
|
Ploidies | 1 | 2013 | 287 | 0.030 |
Why?
|
Heterozygote | 1 | 2020 | 2795 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2024 | 26387 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1331 | 0.030 |
Why?
|
RNA, Neoplasm | 1 | 2015 | 748 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2013 | 313 | 0.030 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 1 | 1994 | 163 | 0.030 |
Why?
|
Chromosomes, Human | 1 | 2014 | 437 | 0.030 |
Why?
|
Obesity | 1 | 2015 | 13090 | 0.030 |
Why?
|
HLA-B Antigens | 1 | 2013 | 330 | 0.030 |
Why?
|
Remission Induction | 1 | 2018 | 2413 | 0.020 |
Why?
|
Repressor Proteins | 2 | 2018 | 2979 | 0.020 |
Why?
|
Databases, Factual | 2 | 2018 | 8065 | 0.020 |
Why?
|
F-Box Proteins | 1 | 2013 | 199 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2013 | 478 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 12536 | 0.020 |
Why?
|
Paclitaxel | 1 | 2019 | 1728 | 0.020 |
Why?
|
Cell Membrane | 1 | 2001 | 3642 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 1144 | 0.020 |
Why?
|
Estrogens | 1 | 2018 | 1528 | 0.020 |
Why?
|
Virus Integration | 1 | 2013 | 307 | 0.020 |
Why?
|
Gene Silencing | 1 | 2018 | 1505 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2019 | 3610 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2015 | 11062 | 0.020 |
Why?
|
Cell Survival | 1 | 2021 | 5749 | 0.020 |
Why?
|
Urinary Bladder | 1 | 2017 | 1155 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 6105 | 0.020 |
Why?
|
Infant | 2 | 2024 | 36459 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2019 | 2571 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2016 | 938 | 0.020 |
Why?
|
Child, Preschool | 2 | 2024 | 42577 | 0.020 |
Why?
|
GTPase-Activating Proteins | 1 | 2013 | 467 | 0.020 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 1994 | 572 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2011 | 655 | 0.020 |
Why?
|
Substrate Specificity | 1 | 1994 | 1750 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2018 | 2456 | 0.020 |
Why?
|
Cell Cycle | 1 | 2018 | 2925 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2018 | 3157 | 0.020 |
Why?
|
DNA Primers | 1 | 1994 | 2826 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2018 | 2875 | 0.020 |
Why?
|
DNA, Mitochondrial | 1 | 2014 | 872 | 0.020 |
Why?
|
Alleles | 1 | 2020 | 6896 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2015 | 2510 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2019 | 22248 | 0.020 |
Why?
|
Phylogeny | 1 | 2016 | 2840 | 0.020 |
Why?
|
Methylation | 1 | 2011 | 1076 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2001 | 18986 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2024 | 8045 | 0.020 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2015 | 1097 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2016 | 1998 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2025 | 65286 | 0.020 |
Why?
|
Papillomaviridae | 1 | 2013 | 1139 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 1994 | 2001 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2018 | 4249 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2021 | 7612 | 0.020 |
Why?
|
Wound Healing | 1 | 2018 | 2800 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2013 | 1110 | 0.020 |
Why?
|
Cell Movement | 1 | 2019 | 5204 | 0.020 |
Why?
|
Antibodies | 1 | 1995 | 2421 | 0.020 |
Why?
|
Enzyme Inhibitors | 2 | 2011 | 3723 | 0.020 |
Why?
|
Time Factors | 2 | 2015 | 40149 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2020 | 4652 | 0.020 |
Why?
|
Mice, SCID | 1 | 2011 | 2626 | 0.020 |
Why?
|
Computational Biology | 1 | 2018 | 3564 | 0.020 |
Why?
|
Carcinoma | 1 | 2017 | 2325 | 0.020 |
Why?
|
Tumor Burden | 1 | 2011 | 1902 | 0.020 |
Why?
|
Models, Molecular | 1 | 2015 | 5388 | 0.020 |
Why?
|
Quinazolines | 1 | 2011 | 1367 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10745 | 0.010 |
Why?
|
DNA | 1 | 2018 | 7210 | 0.010 |
Why?
|
Citric Acid Cycle | 1 | 2005 | 230 | 0.010 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2013 | 1900 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2744 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2014 | 3702 | 0.010 |
Why?
|
Recurrence | 1 | 2016 | 8507 | 0.010 |
Why?
|
Genotype | 1 | 2018 | 13036 | 0.010 |
Why?
|
Risk Assessment | 1 | 2025 | 24299 | 0.010 |
Why?
|
Sex Factors | 1 | 2017 | 10619 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2000 | 11657 | 0.010 |
Why?
|
Macrophages | 1 | 2018 | 5784 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2017 | 12430 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2013 | 5502 | 0.010 |
Why?
|
Algorithms | 1 | 2022 | 14073 | 0.010 |
Why?
|
Papillomavirus Infections | 1 | 2013 | 1639 | 0.010 |
Why?
|
Nocodazole | 1 | 2001 | 95 | 0.010 |
Why?
|
Glycolysis | 1 | 2005 | 837 | 0.010 |
Why?
|
Thiazolidines | 1 | 2001 | 70 | 0.010 |
Why?
|
Lung | 1 | 2020 | 10068 | 0.010 |
Why?
|
Peptide Fragments | 1 | 1994 | 5143 | 0.010 |
Why?
|
Liver | 1 | 2017 | 7571 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 20146 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2017 | 4356 | 0.010 |
Why?
|
Glucose Transporter Type 4 | 1 | 2001 | 241 | 0.010 |
Why?
|
Antimetabolites | 1 | 2001 | 128 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9546 | 0.010 |
Why?
|
Deoxyglucose | 1 | 2001 | 322 | 0.010 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2001 | 148 | 0.010 |
Why?
|
Electroporation | 1 | 2001 | 238 | 0.010 |
Why?
|
Endothelin-1 | 1 | 2001 | 297 | 0.010 |
Why?
|
Androstadienes | 1 | 2001 | 348 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13642 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15425 | 0.010 |
Why?
|
Genes, Dominant | 1 | 2001 | 855 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2017 | 12808 | 0.010 |
Why?
|
Adenoviridae | 1 | 2001 | 1093 | 0.010 |
Why?
|
Body Mass Index | 1 | 2015 | 13050 | 0.010 |
Why?
|
Receptors, Estradiol | 1 | 1996 | 18 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2011 | 14473 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1996 | 826 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2013 | 22351 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2005 | 2903 | 0.010 |
Why?
|
Thiazoles | 1 | 2001 | 1529 | 0.010 |
Why?
|
Glucose | 1 | 2005 | 4340 | 0.010 |
Why?
|
Protein Conformation | 1 | 2001 | 3948 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 74889 | 0.010 |
Why?
|
Phosphotransferases | 1 | 1993 | 302 | 0.010 |
Why?
|
RNA | 1 | 2001 | 2715 | 0.010 |
Why?
|
Enzyme Activation | 1 | 1996 | 3587 | 0.010 |
Why?
|
United States | 1 | 2017 | 72945 | 0.010 |
Why?
|
Estradiol | 1 | 1996 | 1947 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 36570 | 0.000 |
Why?
|